Pathogenesis of HIV-associated lipodystrophy.
Wanke
C
C
D016475:3T3 Cells; D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D004272:DNA, Mitochondrial / Q000187:drug effects / Q000378:metabolism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology* / Q000235:genetics; D051379:Mice; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
D004272:DNA, Mitochondrial; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors